OEM answer: Every lyophilized powder or peptide project can be screened for a suitable OEM route. The exact process depends on identity, end use, packaging, artwork, testing and destination rules. A sample and signed specification come before commercial production.
- Gather requirementsProduct, quantity, market and intended use.
- Targeted R&DFeasibility, formulation and process review.
- Sample testingAnalytical scope and buyer feedback.
- Finalize sampleRecord approved target specification.
- Tailored designVial, label, carton and insert language.
- Approve designCheck claims, codes and artwork.
- Sign contractAgree on MOQ, lead time and terms.
- Box prototypeInspect physical packaging proof.
- Approve prototypeAuthorize a production standard.
- Start productionRelease against approved records.
What the buyer should send
Share the product identity or sequence, target strength or bulk quantity, annual forecast, destination, desired container and closure, artwork status, required tests and documentation. We use this information to define feasibility and avoid quoting an unsuitable format. For cosmetic delivery systems, provide the intended application and local claims requirements. For research materials, specify the laboratory or industrial end use. Prototype and batch records are reviewed separately; public packaging images are design concepts and do not represent a completed batch. During supplier qualification, connect each public statement to the current project. Record the product identity, legal entity, manufacturing or service location, specification owner, test methods, packaging configuration and destination. Request source documents when a capability, certificate or batch result affects approval. Confirm which information describes a general platform and which applies to the quoted route. The written quotation and signed specification should resolve open values, responsibilities and approval points before sampling, production or shipment.